Your browser doesn't support javascript.
loading
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.
Bobisse, Sara; Bianchi, Valentina; Tanyi, Janos L; Sarivalasis, Apostolos; Missiaglia, Edoardo; Pétremand, Rémy; Benedetti, Fabrizio; Torigian, Drew A; Genolet, Raphael; Barras, David; Michel, Alexandra; Mastroyannis, Spyridon A; Zsiros, Emese; Dangaj Laniti, Denarda; Tsourti, Zoi; Stevenson, Brian J; Iseli, Christian; Levine, Bruce L; Speiser, Daniel E; Gfeller, David; Bassani-Sternberg, Michal; Powell, Daniel J; June, Carl H; Dafni, Urania; Kandalaft, Lana E; Harari, Alexandre; Coukos, George.
Afiliación
  • Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.
  • Bianchi V; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Tanyi JL; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.
  • Sarivalasis A; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Missiaglia E; Center for Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Pétremand R; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Benedetti F; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Torigian DA; Institute of Pathology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Genolet R; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.
  • Michel A; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Mastroyannis SA; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.
  • Zsiros E; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Dangaj Laniti D; Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Tsourti Z; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.
  • Stevenson BJ; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Iseli C; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.
  • Levine BL; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Speiser DE; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.
  • Gfeller D; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Bassani-Sternberg M; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Powell DJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • June CH; Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Dafni U; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.
  • Kandalaft LE; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Harari A; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
  • Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.
Nat Cancer ; 4(10): 1410-1417, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37735588
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Vacunas Límite: Female / Humans Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Vacunas Límite: Female / Humans Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article País de afiliación: Suiza